focus
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Trial using CRISPR to edit HIV out of cells disappoints
Next article: Trial using CRISPR to edit HIV out of cells disappoints
knowledge
leisure time
-
Organ aging and disease risk measured by new blood test
2025-09-30 18:03 -
UnitedHealth’s Optum accused of antitrust violations in California
2025-09-30 17:46 -
Pediatric cancer treatments threatened by a new FDA policy
2025-09-30 16:27 -
Despite FDA concern, risk that CAR
2025-09-30 16:22 -
Covid silver lining: Unprecedented look at human immune system
2025-09-30 16:21 -
What to do when lifesaving products contribute to climate change
2025-09-30 16:10